ATE497767T1 - Verfahren zur behandlung von entzündungserkrankungen - Google Patents

Verfahren zur behandlung von entzündungserkrankungen

Info

Publication number
ATE497767T1
ATE497767T1 AT07864191T AT07864191T ATE497767T1 AT E497767 T1 ATE497767 T1 AT E497767T1 AT 07864191 T AT07864191 T AT 07864191T AT 07864191 T AT07864191 T AT 07864191T AT E497767 T1 ATE497767 T1 AT E497767T1
Authority
AT
Austria
Prior art keywords
pharmaceutically acceptable
inflammatory diseases
acceptable salts
treating inflammatory
compounds
Prior art date
Application number
AT07864191T
Other languages
English (en)
Inventor
Andrew Reaume
Heather Hain
Michael Saporito
Original Assignee
Melior Discovery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melior Discovery Inc filed Critical Melior Discovery Inc
Application granted granted Critical
Publication of ATE497767T1 publication Critical patent/ATE497767T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Surgical Instruments (AREA)
AT07864191T 2006-11-10 2007-11-09 Verfahren zur behandlung von entzündungserkrankungen ATE497767T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86531506P 2006-11-10 2006-11-10
PCT/US2007/084214 WO2008060982A1 (en) 2006-11-10 2007-11-09 Methods for treating inflammatory conditions

Publications (1)

Publication Number Publication Date
ATE497767T1 true ATE497767T1 (de) 2011-02-15

Family

ID=39401998

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07864191T ATE497767T1 (de) 2006-11-10 2007-11-09 Verfahren zur behandlung von entzündungserkrankungen

Country Status (5)

Country Link
US (3) US8716294B2 (de)
EP (1) EP2083824B1 (de)
AT (1) ATE497767T1 (de)
DE (1) DE602007012458D1 (de)
WO (1) WO2008060982A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608094B2 (en) * 1999-10-06 2003-08-19 Torrent Pharmaceuticals Ltd. Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
US20060286046A1 (en) * 2005-01-05 2006-12-21 Haber C Andrew Skin care compositions
EP2932958A1 (de) * 2007-02-22 2015-10-21 Beiersdorf AG Kosmetische und pharmazeutische Anwendungen von N-acetylhydroxyprolin

Also Published As

Publication number Publication date
DE602007012458D1 (de) 2011-03-24
US8716294B2 (en) 2014-05-06
US20170173004A1 (en) 2017-06-22
US20080161319A1 (en) 2008-07-03
EP2083824A1 (de) 2009-08-05
WO2008060982A1 (en) 2008-05-22
US20140227209A1 (en) 2014-08-14
EP2083824A4 (de) 2009-11-25
US9408844B2 (en) 2016-08-09
EP2083824B1 (de) 2011-02-09

Similar Documents

Publication Publication Date Title
ATE495743T1 (de) Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
DE602007006010D1 (de) Triazolopyrazinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
RU2018145985A (ru) Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений
EP1572075A4 (de) Verfahren zur behandlung von krankheiten in verbindung mit abnormaler kinasewirkung
EA200970483A1 (ru) Применение пролекарств габапентина и прегабалина для лечения шума в ушах
MX2008012479A (es) Tratamiento de enfermedades neurodegenerativas.
MY163275A (en) Ibat inhibitors for the treatment of liver diseases
CR11580A (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf
EA201001639A1 (ru) Композиции и способы их получения и применения
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
MX2011012015A (es) Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer.
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
CY1115081T1 (el) Νεο εκχυλισμα απο γαϊδουραγκαθο, μεθοδος για την παρασκευη και η χρηση του
AR050717A1 (es) Composiciones farmaceuticas
WO2010044585A3 (en) Piperidine compounds, pharmaceutical composition comprising the same and its use
EP4582141A3 (de) Orale zusammensetzung zur behandlung von gastroösophagealem reflux und laryngopharyngealem reflux
DE602006019468D1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
HK1257171A1 (zh) 间变性淋巴瘤激酶（alk）和丝氨酸富集蛋白激酶 （sppk）的抑制剂及其使用方法
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
EA200970164A1 (ru) Ингибиторы каспазы на основе пиридазинонового каркаса
AR094241A1 (es) Ciclesonida para el tratamiento de la enfermedad de las vias respiratorias en caballos
WO2009155070A3 (en) Compositions and methods for treatment of inflammation and hyperkeratotic lesions
IT1397446B1 (it) Compositions comprising amino acids for prevention and/or treatment of renal disorders.
ATE533488T1 (de) Verfahren und formulierungen zur modulierung von lyn-kinaseaktivität und behandlung assoziierter erkrankungen
WO2007108004A3 (en) S-alkylisothiouronium derivatives for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties